Donate to Remove ads

Got a credit card? use our Credit Card & Finance Calculators

Thanks to johnstevens77,Bhoddhisatva,scotia,Anonymous,Cornytiv34, for Donating to support the site

Circassia (CIR)

Discuss Stock buying Shares, tips and ideas for stock market dealing
Proselenes
Lemon Quarter
Posts: 1372
Joined: November 15th, 2016, 6:04 am
Has thanked: 58 times
Been thanked: 389 times

Circassia (CIR)

#271608

Postby Proselenes » December 17th, 2019, 3:48 am

I found the write up quite compelling and Richard Griffiths is no mug and now the largest holder, certainly worth having some. in my view.

The write up was from Finncap in September, PDF download link below:

https://ufile.io/u2v6r5ve

.

Web site is https://www.circassia.com/

Currently some insti selling and others buying. Looks primed now for cash generation in 2020 and moving to profits in 2021. No need for any further fund raising. Products in Respiratory area, which is fast growing in some aspects of their business due to all the air pollution around now.

Certainly a good idea for a share to hold for the coming couple of years, significant potential in my view.

schober
Lemon Pip
Posts: 71
Joined: November 30th, 2017, 11:14 am
Has thanked: 1 time
Been thanked: 20 times

Re: Circassia (CIR)

#273892

Postby schober » December 29th, 2019, 8:29 pm

Some interesting comment on the two allergy failures in 2016/17
https://pharmaphorum.com/views-and-anal ... -grainger/

Proselenes
Lemon Quarter
Posts: 1372
Joined: November 15th, 2016, 6:04 am
Has thanked: 58 times
Been thanked: 389 times

Re: Circassia (CIR)

#276095

Postby Proselenes » January 9th, 2020, 7:40 am


Proselenes
Lemon Quarter
Posts: 1372
Joined: November 15th, 2016, 6:04 am
Has thanked: 58 times
Been thanked: 389 times

Re: Circassia (CIR)

#276096

Postby Proselenes » January 9th, 2020, 7:43 am

Comment from Finncap.


Morning Note 9 January 2020

Circassia issued a positive trading update for the year to 31 December 2019, with revenues expected to be in the middle of its £60-65m guidance range and in line with our forecasts. Year-end cash was c.£11m higher than our expectations at £27m, due to working capital timing (delayed payment for Tudorza and Duaklir inventory and boosted by third-party rebates). Stripping out these timing effects, there was a modest H2 2019 cash outflow (we estimate to have been c.£5m), which nevertheless contrasts starkly with the £20m outflow in H1 and underpins our view that the business will be EBITDA positive in 2020. We reiterate our target price of 80p, which is supported by premium revenue growth (2-year CAGR of 30%), cash generation and deleveraging balance sheet

.

Proselenes
Lemon Quarter
Posts: 1372
Joined: November 15th, 2016, 6:04 am
Has thanked: 58 times
Been thanked: 389 times

Re: Circassia (CIR)

#276126

Postby Proselenes » January 9th, 2020, 10:20 am

Broker update (PDF file):

https://ufile.io/oxb7jswv

.

Proselenes
Lemon Quarter
Posts: 1372
Joined: November 15th, 2016, 6:04 am
Has thanked: 58 times
Been thanked: 389 times

Re: Circassia (CIR)

#276373

Postby Proselenes » January 10th, 2020, 10:39 am

NIOX sales in China were up nearly 200% at the interims, massive growth there.

And the new version will also enhance more sales growth moving forward.

https://www.nsmedicaldevices.com/analys ... diagnosis/

.

Proselenes
Lemon Quarter
Posts: 1372
Joined: November 15th, 2016, 6:04 am
Has thanked: 58 times
Been thanked: 389 times

Re: Circassia (CIR)

#276466

Postby Proselenes » January 10th, 2020, 4:02 pm

Nice to see.

Assume that its more of the Invesco overhang being cleared.

https://www.investegate.co.uk/cip-merch ... 18334967Z/

.


Return to “Stocks and Share Dealing Discussions”

Who is online

Users browsing this forum: No registered users and 4 guests